Status:
COMPLETED
Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin Conditions and Inflammatory Related Factors
Lead Sponsor:
TCI Co., Ltd.
Conditions:
Skin Conditions
Proinflammatory Cytokines
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
To assess a resveratrol formula on improvement of skin conditions and inflammatory cytokines in blood
Eligibility Criteria
Inclusion
- Healthy volunteers aged above 20 years old
Exclusion
- Subject who is not willing to participate in this study.
- Patients with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history).
- Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
- Female who is pregnant or nursing or planning to become pregnant during the course of the study.
- Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
- Subjects who have large spots (area \>3 square centimeter) or abnormal acne.
Key Trial Info
Start Date :
September 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04456829
Start Date
September 17 2020
End Date
December 31 2020
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chia Nan University of Pharmacy & Science
Tainan, Taiwan, 71710